Webcast Alert: Neurocrine Announces 1Q08 Financial Results

SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Neurocrine Biosciences (Nasdaq: NBIX) announces the following Webcast:

If you are unable to participate during the live webcast, the call will be archived on the Web site http://www.neurocrine.com/.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. The product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com

SOURCE Neurocrine Biosciences

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.